| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | 
|---|---|---|---|---|---|---|
Income Statement  | ||||||
| Total Revenue | 165.88B | 150.22B | 115.50B | 106.38B | 99.25B | 82.54B | 
| Gross Profit | 46.59B | 42.71B | 33.33B | 28.63B | 27.50B | 25.23B | 
| EBITDA | 9.54B | 12.69B | 15.53B | 12.17B | 7.40B | 5.14B | 
| Net Income | 2.69B | 2.76B | 8.71B | 6.19B | 2.83B | 606.00M | 
Balance Sheet  | ||||||
| Total Assets | 233.22B | 236.76B | 187.96B | 171.37B | 168.59B | 164.20B | 
| Cash, Cash Equivalents and Short-Term Investments | 40.02B | 41.73B | 52.56B | 46.49B | 44.53B | 46.26B | 
| Total Debt | 47.87B | 51.17B | 14.93B | 15.50B | 19.78B | 20.62B | 
| Total Liabilities | 108.82B | 109.64B | 60.82B | 59.61B | 58.94B | 60.07B | 
| Stockholders Equity | 117.08B | 119.62B | 120.57B | 105.78B | 104.09B | 98.92B | 
Cash Flow  | ||||||
| Free Cash Flow | 0.00 | -3.45B | 2.41B | 1.86B | 1.15B | 4.58B | 
| Operating Cash Flow | 0.00 | 2.35B | 5.94B | 5.49B | 4.09B | 8.09B | 
| Investing Cash Flow | 0.00 | -30.33B | -744.00M | -1.62B | -1.19B | -1.80B | 
| Financing Cash Flow | 0.00 | 15.27B | -3.02B | -7.09B | -2.75B | -1.14B | 
Name  | Overall Rating  | Market Cap  | P/E Ratio  | ROE  | Dividend Yield  | Revenue Growth  | EPS Growth  | 
|---|---|---|---|---|---|---|---|
| ― | ¥49.38B | 11.25 | 5.36% | 2.97% | 16.00% | ― | |
| ― | ¥49.61B | 11.46 | ― | 3.17% | 9.55% | 17.67% | |
| ― | $57.90B | 20.74 | 2.28% | 4.27% | 42.33% | -66.41% | |
| ― | ¥49.07B | 13.54 | ― | 4.01% | 1.90% | 36.12% | |
| ― | ¥57.91B | 12.66 | ― | 2.96% | 2.79% | -14.83% | |
| ― | ¥55.00B | 22.54 | ― | 2.91% | 9.31% | -62.88% | |
| ― | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | 
Sintokogio, Ltd. reported a significant increase in net sales for the three months ended June 30, 2025, with a 60.8% rise compared to the previous year. Despite the rise in sales, the company experienced a decline in ordinary profit and profit attributable to owners of the parent, indicating challenges in maintaining profitability. The financial outlook for the fiscal year ending March 31, 2026, remains optimistic with expected growth in net sales and operating profit, suggesting potential recovery and growth opportunities.